Quanex Building Products Corporation (NX) Stock Forecast
Data as of May 10, 2026Industrials · Current price $20.26 (+0.90%)
Consensus Target
—
Upside
—
Analysts
1
Rating
Buy(2.00)
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
No ratings in the last 3 months.
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
No analyst price targets available.
NX vs Sector & Market
| Metric | NX | Industrials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.41 | 2.41 |
| Analyst Count | 1 | 9 | 19 |
| Target Upside | — | +79.5% | +16.4% |
| P/E Ratio | -3.84 | 28.58 | 27.60 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-07-31 | $495M | $497M | $499M | 2 |
| 2026-10-31 | $493M | $495M | $497M | 1 |
| 2027-01-31 | $413M | $416M | $417M | 1 |
| 2027-04-30 | $462M | $464M | $466M | 1 |
| 2027-07-31 | $505M | $508M | $509M | 1 |
| 2027-10-31 | $505M | $508M | $509M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-07-31 | $0.75 | $0.75 | $0.76 | 2 |
| 2026-10-31 | $0.85 | $0.85 | $0.86 | 1 |
| 2027-01-31 | $-0.05 | $-0.04 | $-0.04 | 1 |
| 2027-04-30 | $0.45 | $0.46 | $0.46 | 1 |
| 2027-07-31 | $0.86 | $0.87 | $0.87 | 1 |
| 2027-10-31 | $1.00 | $1.00 | $1.01 | 1 |
Frequently Asked Questions
What is the analyst consensus for NX?
The consensus among 1 analysts covering Quanex Building Products Corporation (NX) is Buy with an average price target of N/A.
How many analysts cover NX?
1 analysts have issued ratings for Quanex Building Products Corporation in the past 12 months.
Is NX a buy or sell right now?
Based on 1 analyst ratings, NX has a consensus rating of Buy (2.00/5) with a N/A upside to the consensus target of N/A.
What are the earnings estimates for NX?
Analysts estimate NX will report EPS of $0.75 for the period ending 2026-07-31, with revenue estimated at $497M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.